Barriers to On-Time Follow-up for Barrett's Esophagus After Successful Endoscopic Eradication Therapy

Overview

About this study

The purpose of this study is to elicit patients’ perceptions around their experience with  Barrett's Esophagus (BE) and characterize barriers and potential solutions to care resulting in delayed surveillance or loss to follow-up using a mixed-methods approach.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patient with Barrett's Esophagus (BE) related neoplasia who experienced delayed surveillance or loss to follow-up after achieving complete remission of intestinal metaplasia on or after January 1, 2019.

Exclusion Criteria: 

  • Delay in care resulted as a clear consequence of the SARS-CoV2 pandemic (as documented).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/14/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Allon Kahn, M.D.

Open for enrollment

Contact information:

Brooke Brown

(480) 301-6198

Brown.Brooke@mayo.edu

More information

Publications

Publications are currently not available